Advertisement

Topics

Avexxin Company Profile

17:59 EDT 26th September 2017 | BioPortfolio

Avexxin is a pharmaceutical company focused on developing and commercializing novel small molecule therapeutics for patients with chronic inflammatory conditions. Avexxin's advanced understanding of the biology of the inflammatory process has resulted in a novel therapeutic approach for the treatment of psoriasis and other inflammatory disorders. Our discovery and clinical development expertise is focused on providing disease-modifying drugs addressing inflammatory disorders that are not adequately treated with existing therapies

Location

Norwegian University of Science and TechnologyHøgskoleringen 5
Trondheim
N-7491
Norway

Contact

Phone: 47 73 59 61 07
Fax: 47 73 59 61 00
Email: avexxin@avexxin.com


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Avexxin

Avexxin is a pharmaceutical company focused on developing and commercializing novel small molecule therapeutics for patients with chronic inflammatory conditions. Avexxin's advanced understanding of t...

Avexxin AS

More Information about "Avexxin" on BioPortfolio

We have published hundreds of Avexxin news stories on BioPortfolio along with dozens of Avexxin Clinical Trials and PubMed Articles about Avexxin for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Avexxin Companies in our database. You can also find out about relevant Avexxin Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record